Cognitive impairment in patients receiving antiandrogen therapy

Popović, Alek; Martinić Popović, Irena; Šerić, Vesna; Lovrenčić-Huzjan, Arijana; Šodec- Šimičević, Darja; Šimundić, Ana-Maria; Bašić Kes, Vanja

Pregled bibliografske jedinice broj: 663518

Cognitive impairment in patients receiving antiandrogen therapy

Popović, Alek; Martinić Popović, Irena; Šerić, Vesna; Lovrenčić-Huzjan, Arijana; Šodec- Šimičević, Darja; Šimundić, Ana-Maria; Bašić Kes, Vanja

Cognitive impairment in patients receiving antiandrogen therapy // Periodicum biologorum, Vol 115, Suppl.1 / Branko Vitale (ur.).
Zagreb, 2013. str. 78-79 (poster, domaća recenzija, sažetak, znanstveni)

CROSBI ID: 663518 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Cognitive impairment in patients receiving antiandrogen therapy

Autori
Popović, Alek ; Martinić Popović, Irena ; Šerić, Vesna ; Lovrenčić-Huzjan, Arijana ; Šodec- Šimičević, Darja ; Šimundić, Ana-Maria ; Bašić Kes, Vanja

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Periodicum biologorum, Vol 115, Suppl.1 / Branko Vitale - Zagreb, 2013, 78-79

Skup
53rd International Neuropsychiatric Pula Congress

Mjesto i datum
Pula, Hrvatska, 19.06.2013. - 22.06.2013

Vrsta sudjelovanja
Poster

Vrsta recenzije
Domaća recenzija

Ključne riječi
antiandrogen therapy; prostate cancer; cognitive impairment

Sažetak
Cognitive abilities and serum testosterone levels naturally decline with age. Low serum testosterone levels are known to be associted with increased vascular risk and musculoscteletal, but also with neurological and psychiatric cognitive consenquences.Patients with locally advanced prostate cancer, which is hormone sensitive/dependent, are often treated using antiandrogene therapy, which artificially further lowersserum testosterone levels until castration levels are reached.Our aim was to evaluate the relationship of cognitive changes and serum testosterone levels in patients with prostate cancerreceiving antiandrogene therapy.Although indications for antiandrogene therapy in patients with prostate cancer are nowadays expanding, clinicians need to be well-aware of its side-effects, including cognitive impairment.MoCA can be used as a practical tool for evaluation and follow-up of cognitive changes in those patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA

Projekti:
134-1340036-0033 - Uloga genetskih markera u razvoju cerebralne aterosklerotske bolesti (Demarin, Vida, MZOS ) ( CroRIS)
134-1340036-0034 - Funkcijska dijagnostika moždane cirkulacije (Lovrenčić-Huzjan, Arijana, MZOS ) ( CroRIS)
134-1340036-0035 - Uloga vaskularnih čimbenika rizika u patogenezi Alzheimerove bolesti (Trkanjec, Zlatko, MZOS ) ( CroRIS)
134-1340227-0200 - Upala i udio farmakogenetike u razvoju i ishodu akutnih i kroničnih bolesti (Šimundić, Ana-Maria, MZOS ) ( CroRIS)
143-1080002-0050 - Dijagnostika i liječenje bolesnika sa sindromom prostatitisa (Škerk, Višnja, MZOS ) ( CroRIS)